Skip to main content Skip to main content
VitalDecades logo VitalDecades

Biomarker library / Lipids

Triglycerides (TG)

Also called serum triglycerides, TAG

The main form of fat carried in blood, packaged in chylomicrons after a meal and in VLDL particles made by the liver. Triglycerides are a direct read on how the body is handling energy, and they rise with insulin resistance.

By , Longevity & Research Sources checked Corrected How pages are checked

01  /  Reference ranges

What counts as normal

Chart of the Triglycerides scale in mg/dL: Normal under 150; Borderline high 150 to 199; High 200 to 499; Very high 500 or higher.
Scale in mg/dL. Cut points from the sources listed below.

Save this result

Stored on your account and never shared. We are not sending email yet, so band-change alerts will not arrive until we turn sending on. Export or delete it any time from My numbers.

Population Adults, fasting (ATP III)
Category Normal
Range under 150 mg/dL
Population Adults, fasting (ATP III)
Category Borderline high
Range 150 to 199 mg/dL
Population Adults, fasting (ATP III)
Category High
Range 200 to 499 mg/dL
Population Adults, fasting (ATP III)
Category Very high
Range 500 or higher mg/dL
Population Adults without ASCVD, 10-year risk 3% to under 5% (2026 ACC/AHA), nonfasting sample
Category Risk-enhancing factor: persistently elevated
Range 175 or higher mg/dL
Population Adults without ASCVD, 10-year risk 3% to under 5% (2026 ACC/AHA), fasting sample
Category Risk-enhancing factor: persistently elevated
Range 150 or higher mg/dL

Normal vs optimal

Normal is under 150 mg/dL (ATP III), the lowest of its four categories, and ATP III sets it on a fasting sample. Neither ATP III nor the 2026 ACC/AHA guideline names an optimal triglyceride level, and the 2026 guideline puts no number on a normal adult one. For a nonfasting sample the line is 175 mg/dL: the 2016 European consensus on nonfasting lipid testing flags a nonfasting triglyceride of 175 (2 mmol/L) or higher, and the 2026 ACC/AHA guideline counts triglycerides persistently at 175 or higher nonfasting, or 150 or higher fasting, as a risk enhancer.

02  /  Why it matters

What the number tells you

NCEP ATP III set the categories most labs still print: normal under 150 mg/dL, borderline high 150 to 199, high 200 to 499, very high 500 and above. The 2026 ACC/AHA dyslipidemia guideline, which retired the 2018 AHA/ACC guideline in March 2026, counts triglycerides persistently at 175 mg/dL or higher on a nonfasting sample, or 150 or higher fasting, as a risk enhancer when weighing lipid-lowering therapy for adults without atherosclerotic cardiovascular disease whose 10-year risk is borderline (3 to under 5 percent); 150 mg/dL is also ATP III's metabolic syndrome cutoff. Very high levels (500 and above) carry pancreatitis risk and are managed as a separate problem.

03  /  In practice

Testing and what moves it

When it is tested

  • On every lipid panel. Fasting samples are used to assign the borderline, high and very high categories; a nonfasting sample is an acceptable screen.

What raises it

  • Refined carbohydrate and alcohol intake, insulin resistance and diabetes, obesity, hypothyroidism, kidney disease, some medications, and genetics.

What lowers it

  • Weight loss, less alcohol and refined carbohydrate, more activity, better glucose control; fibrates, omega-3 prescription products and statins in specific situations.

04  /  Related

Frequently asked questions

Do I need to fast for triglycerides?

For most people, no. The 2016 European consensus on nonfasting lipid testing recommends nonfasting samples as the routine and keeps fasting for specific cases, such as a nonfasting triglyceride above 440 mg/dL. Read a nonfasting result against the nonfasting line of 175 mg/dL that the consensus and the 2026 ACC/AHA guideline use, not the fasting 150. The borderline, high and very high categories on this page are ATP III's, which it set on fasting samples.

What is a dangerous triglyceride level?

ATP III calls 500 mg/dL and above very high. The 2026 ACC/AHA guideline says "The risk of acute pancreatitis increases with TG levels ≥500 mg/dL and is particularly high with TG levels ≥1000 mg/dL." Below 1000, "statins remain first-line therapy" to lower cardiovascular risk; at 1000 or higher, "initial priority should be given to lowering TG to reduce the risk of pancreatitis." None of the documents behind this page names a triglyceride number that by itself calls for emergency care.

2 documents set the numbers on this page. The oldest was published in 2001, the newest in 2026.

We last re-read these sources on . How we verify.

Edited by (Longevity & Research). How pages are checked